You are using an outdated browser. Please upgrade your browser to improve your experience.

combined oxidative phosphorylation defect type 13

Disease Summary
Associated Targets (1)
Tbio

1


Mondo Description Combined oxidative phosphorylation defect type 13 is a rare mitochondrial disease due to a defect in mitochondrial protein synthesis characterized by normal early development followed by the sudden onset in infancy of poor feeding, dysphagia, truncal (followed by global) hypotonia, motor regression, abnormal movements (i.e. severe dystonia of limbs, choreoathetosis, facial dyskinesias) and reduced tendon reflexes. The disease course is severe but nonprogressive.
Uniprot Description A mitochondrial disorder characterized by early onset severe encephalomyopathy, dystonia, choreoathetosis, bucofacial dyskinesias and combined mitochondrial respiratory chain deficiency. Nerve conductions velocities are decreased. Levels of plasma and cerebrospinal fluid lactate are increased.
Mondo Term and Equivalent IDs
MONDO:0013977:  combined oxidative phosphorylation defect type 13
DOID:0111467: 
Orphanet:319514: 
SCTID:763110007: 
UMLS:C3554129: